Although the dominant factors of each phase overlap significantly, it has been observed that there is a predominance of tumour-derived growth factors in the first phase (GM-CSF and G-CSF) and later, in the second cytokine phase, of pro-inflammatory diseases derived from the tumour stroma (IL-1b or IL-6) [151]. The gene discussed is CSF2; the disease is neoplasm.